According to a new report by Polaris Market Research, the global mammography market was valued at USD 2,725.89 million in 2024 and is projected to reach USD 6,205.87 million by 2034, expanding at a CAGR of 8.6% over the forecast period. Growth is underpinned by the rising prevalence of breast cancer, expanding government-led screening programs, and accelerating adoption of digital and 3D imaging technologies across key end-use industries.

What Is Driving Mammography Market Growth?

Demand is climbing as the rising global incidence of breast cancer converges with growing awareness of early detection and expanding government screening initiatives. Manufacturers and healthcare providers are prioritizing digital and AI-enabled imaging, pushing mammography adoption across hospitals, breast care centers, and academic institutions. Polaris analysts note that with over 355,000 new breast cancer cases reported in Europe in 2021 alone, the market is positioned for sustained growth through 2034, with the standalone modality emerging as the largest revenue contributor and multimodal systems posting the fastest incremental gains.

Key Trends Shaping the Mammography Industry

Shift to Digital and 3D Tomosynthesis Imaging

Providers are transitioning from analog to digital mammography and adopting 3D breast tomosynthesis to improve image clarity, reflecting a broader wave of product innovation and technology advancement across breast imaging.

Government Screening Programs and Awareness Campaigns

Public initiatives such as national screening programs in Japan and Australia and awareness campaigns in Germany are shaping the regulatory landscape and expanding access to routine mammography services.

AI Integration and Expanding Access via Retail Partnerships

Vendors are integrating AI-driven diagnostic tools to speed image interpretation while expanding access through mobile units and retail-based screening programs, a shift reflected in the industry's competitive landscape and near-term investment outlook.

Market Segmentation: Breaking Down the Mammography Market

Polaris segments the mammography market by modality, application, end use, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Modality

The Standalone segment held the larger market share in 2024, driven by its widespread adoption in routine breast cancer screening programs and its established efficacy and accessibility. The Multimodal segment is experiencing a higher growth rate as recognition grows of standalone systems' limitations in detecting cancers in dense breast tissue, with combined mammography-ultrasound approaches improving diagnostic sensitivity and specificity.

By Application

Diagnostic Screening remains the dominant application, driven by widespread government-funded breast screening programs aimed at early cancer detection. Advance Imaging is gaining share as adoption of enhanced diagnostic technologies grows, signaling where near-term demand — and search intent around "3D mammography screening" — is shifting.

By End Use

Among end-use categories, Hospitals captured the largest share in 2024, supported by the high volume of breast cancer screenings conducted in hospital settings and continuous technological upgrades to mammography workstations, while Breast Care Centers and Academia are expected to post meaningful incremental growth as specialized screening facilities expand.

Regional Outlook: Where Is the Mammography Market Growing Fastest?

North America led the market in 2024 on the back of the region's high breast cancer incidence and advanced healthcare infrastructure, while Europe is expected to post continued growth driven by rising breast cancer prevalence and government screening initiatives such as Germany's 'Breast Cancer Affects Us All' campaign. Asia Pacific is witnessing significant growth as countries such as Japan and Australia expand national screening programs, with rising healthcare spending fueling demand across the region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/mammography-market 

Competitive Landscape: Leading Mammography Companies

Key players profiled in the report include Hologic, Inc., Siemens Healthineers AG, GE HealthCare, Fujifilm Holdings Corporation, and Koninklijke Philips N.V., who are focusing on product launches and R&D investment to strengthen market position across the Standalone and Diagnostic Screening segments outlined above. Recent moves include GE HealthCare's November 2024 launch of the Pristina Via mammography system, offering vendor-neutral prior image comparison and reduced radiation doses, and Siemens Healthineers' September 2024 FDA premarket approval for the 3D imaging technology in its Mammomat B.brilliant system, both aimed at deepening share in North America and Europe.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the mammography market forecast, this report benchmarks market share, segment-level pricing, and forecast data — by modality, application, end use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking multimodal imaging as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

Substance Abuse Treatment Market

Recycling Water Filtration Market

Drone Batteries Market

Pad-mounted Switchgear Market

Recycling Water Filtration Market

Automotive Tire Market

Next-generation Sequencing Library Preparation Market

Electric Vehicle (EV) Charging Infrastructure Market: Speeding Up the Passage to Electric Mobility

Riflescope & Red dot sight market